Insider Profile
Emery, David Joseph
1
Companies Filed At
1
Open-Market Buys (2yr)
$190K
Buy Value (2yr, open-market)
May 19, 2026
Most Recent Trade
34
Credibility
Score
100%
Hit Rate
+5.5%
Avg 90d Return
+5.9%
Median 90d Return
6
Evaluated Trades
+6.0%
Best Trade
+3.6%
Worst Trade
Hit rate and returns are based on 6 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
Hit Rate · 90d
-18.3%
Median Alpha · 90d
1
Closed Buys Evaluated
0%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 1 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
May 19, 2026 $STN
Stantec
Comp. Grant Buy 1,200 45
Dec 31, 2025 $STN
Stantec
Plan / DRIP Buy 175 $134.44 $24K 45
Nov 24, 2025 $STN
Stantec
Open Market Buy 1,427 $133.25 $190K 45
Jun 20, 2025 $STN
Stantec
Other Sell 1,438 $143.72 $207K 45
Jun 20, 2025 $STN
Stantec
Other Sell 359 $133.69 $48K 45
May 20, 2025 $STN
Stantec
Comp. Grant Buy 926 45
Dec 31, 2024 $STN
Stantec
Plan / DRIP Buy 7 $113.65 $796 45
Dec 31, 2024 $STN
Stantec
Plan / DRIP Buy 26 $113.50 $3K 45
Dec 31, 2024 $STN
Stantec
Plan / DRIP Buy 217 $112.84 $24K 45
Jun 21, 2024 $STN
Stantec
Other Sell 1,437 $174.15 $250K 45
Jun 21, 2024 $STN
Stantec
Other Sell 360 $115.10 $41K 45
Dec 31, 2023 $STN
Stantec
Plan / DRIP Buy 24 $93.91 $2K 45
Dec 31, 2023 $STN
Stantec
Plan / DRIP Buy 6 $93.91 $563 45
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.